Skip to main content
SpringerLink
Log in

Low prevalence of cardiac siderosis in heavily iron loaded Egyptian thalassemia major patients

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Myocardial siderosis in thalassemia major remains the leading cause of death in developing countries. Once heart failure develops, the outlook is usually poor with precipitous deterioration and death. Cardiovascular magnetic resonance (CMR) can measure cardiac iron deposition directly using the magnetic relaxation time T2*. This allows earlier diagnosis and treatment and helps to reduce mortality from this cardiac affection. This study aims to determine the prevalence of cardiac siderosis in Egyptian patients who are heavily iron loaded and its relation to liver iron concentration, serum ferritin, and left ventricular ejection fraction. Eighty-nine β-thalassemia patients receiving chelation therapy (mean age of 20.8 ± 6.4 years) were recruited in this study. Tissue iron levels were determined by CMR with cardiac T2* and liver R2*. The mean ± standard deviation (range) of cardiac T2* was 28.5 ± 11.7 ms (4.3 to 53.8 ms), the left ventricular ejection fraction (LVEF) was 67.7 ± 4.7 % (55 to 78 %), and the liver iron concentration (LIC) was 26.1 ± 13.4 mg Fe/g dry weight (dw) (1.5 to 56 mg Fe/g dw). The mean serum ferritin was 4,510 ± 2,847 ng/ml (533 to 22,360 ng/ml), and in 83.2 %, the serum ferritin was >2,500 ng/ml. The prevalence of myocardial siderosis (T2* of <20 ms) was 24.7 % (mean age 20.9 ± 7.5 years), with mean T2* of 12.7 ± 4.4 ms, mean LVEF of 68.6 ±5.8 %, mean LIC of 30.9 ± 13 mg Fe/g dw, and median serum ferritin of 4,996 ng/ml. There was no correlation between T2* and age, LVEF, LIC, and serum ferritin (P = 0.65, P = 0.085, P = 0.99, and P = 0.63, respectively). Severe cardiac siderosis (T2* of <10 ms) was present in 7.9 %, with a mean age of 18.4 ± 4.4 years. Although these patients had a mean T2* of 7.8 ± 1.7 ms, the LVEF was 65.1 ± 6.2 %, and only one patient had heart failure (T2* of 4.3 ms and LVEF of 55 %). LIC and serum ferritin results were 29.8 ± 17.0 mg/g and 7,200 ± 6,950 ng/ml, respectively. In this group of severe cardiac siderosis, T2* was also not correlated to age (P = 0.5), LVEF (P = 0.14), LIC (P = 0.97), or serum ferritin (P = 0.82). There was a low prevalence of myocardial siderosis in the Egyptian thalassemia patients in spite of very high serum ferritin and high LIC. T2* is the best test that can identify at-risk patients who can be managed with optimization of their chelation therapy. The possibility of a genetic component for the resistance to cardiac iron loading in our population should be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA, Forni GL, Gamberini MR, Ghilardi R, Piga A, Cnaan A (2004) Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 89:1187–1193

    PubMed  Google Scholar 

  2. Modell B, Khan M, Darlison M (2000) Survival in beta thalassemia major in the UK; data from the UK Thalassemia Register. Lancet 355:2051–2052

    Article  CAS  PubMed  Google Scholar 

  3. Brittenham GM, Griffith PM, Nienhuis AW, Mc Laren CE, Young NS, Tucker EE, Allen CJ, Farrell DE, Harris JW (1994) Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 331:567–573

    Article  CAS  PubMed  Google Scholar 

  4. Davis BA, O’Sullivan C, Jarritt PH, Porter JB (2004) Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major. Blood 104:263–269

    Article  CAS  PubMed  Google Scholar 

  5. Westwood MA, Anderson LJ, Maceira AM, Shah FT, Prescott E, Porter JB, Wonke B, Walker JM, Pennell DJ (2007) Normalized left ventricular volumes and function in thalassemia major patients with normal myocardial iron. J Magn Reson Imaging 25:1147–1151

    Article  PubMed  Google Scholar 

  6. Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM, Pennell DJ (2001) Cardiovascular T2* magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22:2171–2179

    Article  CAS  PubMed  Google Scholar 

  7. Tanner MA, Galanello R, Dessi C, Westwood MA, Smith GC, Nair SV, Anderson LJ, Walker JM, Pennell DJ (2006) Myocardial iron loading in patients with thalassemia major on deferoxamine chelation. J Card Magn Reson 8:543–547

    CAS  Google Scholar 

  8. Westwood M, Anderson LJ, Firmin DN, Gatehouse PD, Charrier CC, Wonke B, Pennell DJ (2003) A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial overload. J Magn Reson Imaging 18:33–39

    Article  PubMed  Google Scholar 

  9. StPierre TG, Clark PR, Chua-anusorn W, Fleming AJ, Jeffrey GP, Olynyk JK, Pootrakul P, Robins E, Lindeman R (2005) Non invasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 105(2):855–861

    Article  CAS  Google Scholar 

  10. St Pierre TG, Clark PR, Chua-Anusorn W (2004) Single spin-echo proton transverse relaxometry of iron-loaded liver. NMR Biomed 17(7):446–458

    Article  PubMed  Google Scholar 

  11. Costongs GMPJ, van Oers RJM, Leerkens B, Hermans W, Janson PCW (1995) Evaluation of the Abbott automated random, immediate and continuous access immunoassay analyser, the AxSYM™. Eur J Clin Chem Clin Biochem 33:105–111

    CAS  PubMed  Google Scholar 

  12. Pennell DJ, Berdoukas V, Karagiorga M, Ladis V, Piga A, Aessopos A, Gotsis ED, Tanner MA, Smith GC, Westwood MA, Wonke B, Galanello R (2006) Randomized controlled trial of deferiprone or deferoxamine in beta thalassemia major patients with asymptomatic myocardial siderosis. Blood 107(9):3738–3744

    Article  CAS  PubMed  Google Scholar 

  13. Tanner MA, Galanello R, Dessi C, Smith GC, Westwood MA, Agus A, Roughton M, Assomull R, Nair SV, Walker JM, Pennell DJ (2007) A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation 115:1876–1884

    Article  CAS  PubMed  Google Scholar 

  14. Wing-Yang A, Winnie WL, Winnie WC, Hui-Leung Y, Alvin SL, Rever CL, Helen MC, Harold KL, Man-Fai L, Herman SL, Raymond L, Shau-Yin H (2008) A cross-sectional magnetic resonance imaging assessment of organ specific hemosiderosis in 180 thalassemia major patients in Hong Kong. Haematologica 93(5):784–785

    Article  Google Scholar 

  15. Chirnomas SD, Geukes-Foppen M, Barry K, Braunstein J, Kalish LA, Neufeld EJ, Powell AJ (2008) Practical implications of liver and heart iron load assessment by T2*-MRI in children and adults with transfusion-dependent anemias. Am J Hematol 83:781–783

    Article  Google Scholar 

  16. Daar S, Pathare AV, Jain R, Al Zadjali S, Pennell DJ (2009) T2* cardiovascular magnetic resonance in the management of thalassemia patients in Oman. Haematologica 94:140–141

    Article  PubMed  Google Scholar 

  17. Patton N, Brown G, Leung M, Bavishi K, Taylor J, Lioyd J, Lee SH, Tay L, Worthley S (2010) Observational study of iron overload assessed by magnetic resonance imaging in an adult population of transfusion dependant patients with beta thalassemia: significant association between low cardiac T2* < 10ms and the occurrence of cardiac events. Int Med J 40:419–426

    Article  CAS  Google Scholar 

  18. Aypar E, Alehan D, Hazirolan T, Gumruk F (2010) The efficacy of tissue Doppler imaging in predicting myocardial iron load in patients with beta thalassemia major: correlation with T2* cardiovascular magnetic resonance. Int J Cardiovasc Imaging 26(4):413–421

    Article  PubMed  Google Scholar 

  19. Noetzli LJ, Carson SM, Nord AS, Coates TD, Wood JC (2008) Longitudinal analysis of heart and liver iron in thalassemia major. Blood 112:2973–2978

    Article  CAS  PubMed  Google Scholar 

  20. Parkes JG, Hussein RA, Olivieri NF, Templeton DM (1993) Effects of iron loading on uptake, speciation, and chelation of iron in cultured myocardial cells. J Lab Clin Med 122:36–47

    CAS  PubMed  Google Scholar 

  21. Randell EW, Parkes JG, Olivieri NF, Templeton DM (1994) Uptake of non-transferrin-bound iron by both reductive and non reductive processes is modulated by intracellular iron. J Biol Chem 269:16046–16053

    CAS  PubMed  Google Scholar 

  22. Cabantchik ZI, Breuer W, Zanninelli G, Cianciulli P (2005) LPI-labile plasma iron in iron overload. Best Pract Res Clin Haematol 18:277–287

    Article  CAS  PubMed  Google Scholar 

  23. Anderson LJ, Westwood MA, Holden S, Davis B, Prescott E, Wonke B, Porter JB, Walker JM, Pennell DJ (2004) Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br J Haematol 127:348–355

    Article  CAS  PubMed  Google Scholar 

  24. Oudit GY, Trivieri MG, Khaper N, Liu PP, Blackx PH (2006) Role of L-type calcium channels in iron transport and iron-overload cardiomyopathy. J Mol Med 84:349–364

    Article  CAS  PubMed  Google Scholar 

  25. Ludwiczek S, Theurl I, Muckenthaler MU, Jakab M, Mair SM, Theurl M, Kiss J, Paulmichl M, Hentze MW, Ritter M, Weiss G (2007) Calcium channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1. Nat Med 13:448–454

    Article  CAS  PubMed  Google Scholar 

  26. Wood JC, Origa R, Agus A, Matta G, Coates TD, Galanello R (2008) Onset of cardiac loading in pediatric patients with thalassemia major. Haematologica 93(6):917–920

    Article  PubMed Central  PubMed  Google Scholar 

  27. Wood JC, Tyszka JM, Ghurge N, Carson S, Nelson MD, Coates TD (2004) Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood 103:1934–1936

    Article  CAS  PubMed  Google Scholar 

  28. Tanner MA, Westwood MA, Galanello R, Pennell DJ (2005) Baseline findings of CMR driven randomized controlled trial of iron chelation therapy in thalassemia major. J Cardiovas Magn Reson 7:31–32

    Google Scholar 

  29. Leonardi B, Margossian R, Colan SD, Powell AJ (2008) Relationship of magnetic resonance imaging estimation of myocardial iron to left ventricular systolic and diastolic function in thalassemia. JACC Cardiovasc Imaging 1(5):579–581

    Article  Google Scholar 

  30. Pennell DJ (2005) T2* magnetic resonance and myocardial iron in thalassemia. Ann N Y Acad Sci 1054:373–378

    Article  CAS  PubMed  Google Scholar 

  31. Bellenger NG, Burgess M, Ray SG, Coats A, Lahiri A, Cleland JGF, The CHRISTMAS Steering Committee and Investigators (2000) Comparison of left ventricular ejection fraction and volumes in heart failure by two-dimensional echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance: are they interchangeable? Eur Heart J 21:1387–1396

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

All authors declare that they have no conflict of interest that may inappropriately influence this work.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Cairo University, Cairo, Egypt

    Amal El Beshlawy, Mona El Tagui, Mona Hamdy, Mona El Ghamrawy & Khaled Abdel Azim

  2. Department of Radiology, Cairo University, Cairo, Egypt

    Doria Salem

  3. Department of Clinical Pathology, Cairo University, Cairo, Egypt

    Fadwa Said

  4. Department of Radiology, Ein Shams University, Cairo, Egypt

    Ahmed Samir

  5. School of Physics, University of Western Australia, Perth, Australia

    Timothy St Pierre

  6. Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and Imperial College, London, UK

    Dudley J Pennell

Authors
  1. Amal El Beshlawy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mona El Tagui
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mona Hamdy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mona El Ghamrawy
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Khaled Abdel Azim
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Doria Salem
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Fadwa Said
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ahmed Samir
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Timothy St Pierre
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Dudley J Pennell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amal El Beshlawy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

El Beshlawy, A., El Tagui, M., Hamdy, M. et al. Low prevalence of cardiac siderosis in heavily iron loaded Egyptian thalassemia major patients. Ann Hematol 93, 375–379 (2014). https://doi.org/10.1007/s00277-013-1876-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-013-1876-0

Keywords

Search

Navigation